PP244—Therapeutic and supra-therapeutic intravenous doses of mavoglurant (AFQ056) do not prolong the QTc interval in healthy subjects

Saved in:
Bibliographic Details
Published in:Clinical therapeutics 2013-08, Vol.35 (8), p.e95-e96
Main Authors: Ufer, M, Tisserant, A, Dodman, A, Voltz, E, Salunke, A, Woessner, R, Sagkriotis, A, Jordaan, P, Legangneux, E
Format: Article
Language:English
Subjects:
Internal Medicine
Intravenous administration
Medical Education
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0149-2918
1879-114X
DOI:10.1016/j.clinthera.2013.07.281